XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.25.1

SEGMENT DATA AND RELATED INFORMATION (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2025
Segment Reporting [Abstract] |
Schedule of segment data and related information |
|  | Three Months Ended March 31, |  |  |  | Nine Months Ended March 31,
(In millions) |  | 2025 |  | 2024 |  |  |  |  |  | 2025 |  | 2024
PRODUCT CATEGORY DATA |  |  |  |  |  |  |  |  |  |  |  |
Net sales: |  |  |  |  |  |  |  |  |  |  |  |
Skin Care |  | $ | 1,807 |  |  | $ | 2,060 |  |  |  |  |  |  | $ | 5,257 |  |  | $ | 5,873 |
Makeup |  | 1,035 |  |  | 1,136 |  |  |  |  |  |  | 3,223 |  |  | 3,365 |
Fragrance |  | 557 |  |  | 575 |  |  |  |  |  |  | 1,931 |  |  | 1,948 |
Hair Care |  | 126 |  |  | 143 |  |  |  |  |  |  | 424 |  |  | 464 |
Other |  | 25 |  |  | 26 |  |  |  |  |  |  | 80 |  |  | 88 |
|  | 3,550 |  |  | 3,940 |  |  |  |  |  |  | 10,915 |  |  | 11,738 |
Returns associated with restructuring and other activities |  | — |  |  | — |  |  |  |  |  |  | — |  |  | (1) |
Net sales |  | $ | 3,550 |  |  | $ | 3,940 |  |  |  |  |  |  | $ | 10,915 |  |  | $ | 11,737 |
Operating income (loss) before charges associated with restructuring and other activities: |  |  |  |  |  |  |  |  |  |  |  |
Skin Care |  | $ | 361 |  |  | $ | 468 |  |  |  |  |  |  | $ | 784 |  |  | $ | 920 |
Makeup |  | 14 |  |  | 66 |  |  |  |  |  |  | (382) |  |  | 56 |
Fragrance |  | 32 |  |  | 29 |  |  |  |  |  |  | (354) |  |  | 267 |
Hair Care |  | (13) |  |  | (25) |  |  |  |  |  |  | (34) |  |  | (50) |
Other |  | 9 |  |  | 11 |  |  |  |  |  |  | (25) |  |  | 38 |
|  | 403 |  |  | 549 |  |  |  |  |  |  | (11) |  |  | 1,231 |
Reconciliation: |  |  |  |  |  |  |  |  |  |  |  |
Charges associated with restructuring and other activities |  | (97) |  |  | (18) |  |  |  |  |  |  | (384) |  |  | (28) |
Interest expense |  | (87) |  |  | (94) |  |  |  |  |  |  | (269) |  |  | (287) |
Interest income and investment income, net |  | 27 |  |  | 45 |  |  |  |  |  |  | 85 |  |  | 126 |
Other components of net periodic benefit cost |  | (5) |  |  | 4 |  |  |  |  |  |  | (10) |  |  | 9 |
Earnings (loss) before income taxes |  | $ | 241 |  |  | $ | 486 |  |  |  |  |  |  | $ | (589) |  |  | $ | 1,051 |
GEOGRAPHIC DATA(1) |  |  |  |  |  |  |  |  |  |  |  |
Net sales: |  |  |  |  |  |  |  |  |  |  |  |
The Americas |  | $ | 1,052 |  |  | $ | 1,117 |  |  |  |  |  |  | $ | 3,462 |  |  | $ | 3,567 |
Europe, the Middle East & Africa |  | 1,358 |  |  | 1,647 |  |  |  |  |  |  | 4,082 |  |  | 4,488 |
Asia/Pacific |  | 1,140 |  |  | 1,176 |  |  |  |  |  |  | 3,371 |  |  | 3,683 |
|  | 3,550 |  |  | 3,940 |  |  |  |  |  |  | 10,915 |  |  | 11,738 |
Returns associated with restructuring and other activities |  | — |  |  | — |  |  |  |  |  |  | — |  |  | (1) |
Net sales |  | $ | 3,550 |  |  | $ | 3,940 |  |  |  |  |  |  | $ | 10,915 |  |  | $ | 11,737 |
Operating income (loss): |  |  |  |  |  |  |  |  |  |  |  |
The Americas |  | $ | 8 |  |  | $ | (6) |  |  |  |  |  |  | $ | (983) |  |  | $ | (243) |
Europe, the Middle East & Africa |  | 239 |  |  | 302 |  |  |  |  |  |  | 645 |  |  | 825 |
Asia/Pacific |  | 156 |  |  | 253 |  |  |  |  |  |  | 327 |  |  | 649 |
|  | 403 |  |  | 549 |  |  |  |  |  |  | (11) |  |  | 1,231 |
Charges associated with restructuring and other activities |  | (97) |  |  | (18) |  |  |  |  |  |  | (384) |  |  | (28) |
Operating income (loss) |  | $ | 306 |  |  | $ | 531 |  |  |  |  |  |  | $ | (395) |  |  | $ | 1,203 |
(1) The net sales from the Company's travel retail business are included in the Europe, the Middle East & Africa region, and operating income attributable to these net sales are included in that region and in The Americas. The exception is for net sales and operating income of Dr.Jart+ in the travel retail channel in Korea that are reflected in Korea in the Asia/Pacific region. During the fiscal 2025 second quarter, the Company exited Dr.Jart+ from the travel retail channel in Korea.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration